Authors:
COTE P
CASSIDY JD
YONGHING K
SIBLEY J
LOEWY J
Citation: P. Cote et al., APOPHYSEAL JOINT DEGENERATION, DISC DEGENERATION, AND SAGITTAL CURVE OF THE CERVICAL-SPINE - CAN THEY BE MEASURED RELIABLY ON RADIOGRAPHS, Spine (Philadelphia, Pa. 1976), 22(8), 1997, pp. 859-864
Authors:
DYKSTRA KH
LOEWY J
SCHWERTSCHLAG U
KAYE JA
Citation: Kh. Dykstra et al., A MATHEMATICAL-MODEL OF THE KINETICS OF PLATELET PRODUCTION AFTER HIGH-DOSE CHEMOTHERAPY AND TREATMENT WITH NEUMEGA(R) (RHIL-11), Blood, 90(10), 1997, pp. 3553-3553
Citation: B. Rawat et J. Loewy, VALUE OF 3-DIMENSIONAL GRADIENT-ECHO MAGNETIC-RESONANCE CHOLANGIOGRAPHY IN DIAGNOSING CHOLEDOCHOLITHIASIS, Canadian Association of Radiologists journal, 47(4), 1996, pp. 265-269
Authors:
HUSSEIN A
VREDENBURGH J
ELKORDY M
RUBIN P
FISHER D
CANALES R
PETROS W
GILBERT C
PERET N
DYKSTRA K
LOEWY J
KAYE JA
PETERS WP
Citation: A. Hussein et al., RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) IN PATIENTS WITH BREAST-CANCERFOLLOWING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL (AHPC) SUPPORT, Experimental hematology, 24(9), 1996, pp. 634-634
Citation: C. Isaacs et al., NEUMEGA(R) (RHIL-11) PREVENTS PLATELET TRANSFUSIONS IN UP TO 4 CYCLESOF DOSE-INTENSE CHEMOTHERAPY IN WOMEN WITH BREAST-CANCER, Blood, 88(10), 1996, pp. 1780-1780
Authors:
GORDON MS
MCCASKILLSTEVENS WJ
BATTIATO LA
LOEWY J
LOESCH D
BREEDEN E
HOFFMAN R
BEACH KJ
KUCA B
KAYE J
SLEDGE GW
Citation: Ms. Gordon et al., PHASE-I TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA RHIL-11 GROWTH-FACTOR) IN WOMEN WITH BREAST-CANCER RECEIVING CHEMOTHERAPY, Blood, 87(9), 1996, pp. 3615-3624
Citation: Dt. Lanigan et J. Loewy, POSTOPERATIVE COMPUTED-TOMOGRAPHY SCAN STUDY OF THE PTERYGOMAXILLARY SEPARATION DURING THE LE-FORT-I OSTEOTOMY USING A MICRO-OSCILLATING SAW, Journal of oral and maxillofacial surgery, 53(10), 1995, pp. 1161-1166
Authors:
ELIAS L
TEPLER I
SMITH JW
HUSSEIN MA
KUCA B
BEACH K
LOEWY J
KAYE JA
Citation: L. Elias et al., RANDOMIZED TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) IN PATIENTS WITH SEVERE CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA, Blood, 86(10), 1995, pp. 1979-1979
Authors:
KAYE JA
LOEWY J
BLUME J
CLENDANIEL A
EGAN A
GARNICK MB
MITCHELL J
KNOWLES C
AULT KA
Citation: Ja. Kaye et al., RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) INCREASES PLASMA VON-WILLEBRAND-FACTOR AND FIBRINOGEN CONCENTRATIONS IN NORMAL HUMAN-SUBJECTS, Blood, 84(10), 1994, pp. 10000276-10000276
Authors:
AULT KA
MITCHELL J
KNOWLES C
CLENDANIEL A
EGAN A
LOEWY J
GARNICK MB
KAYE JA
Citation: Ka. Ault et al., RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM)RHIL-11 GROWTH-FACTOR) INCREASES PLASMA-VOLUME AND DECREASES URINE SODIUM-EXCRETION IN NORMAL HUMAN-SUBJECTS, Blood, 84(10), 1994, pp. 10000276-10000276
Authors:
RUBENSTEIN EB
ROLSTON K
BENJAMIN RS
LOEWY J
ESCALANTE C
MANZULLO E
HUGHES P
MORELAND B
FENDER A
KENNEDY K
HOLMES F
ELTING L
BODEY GP
Citation: Eb. Rubenstein et al., OUTPATIENT TREATMENT OF FEBRILE EPISODES IN LOW-RISK NEUTROPENIC PATIENTS WITH CANCER, Cancer, 71(11), 1993, pp. 3640-3646